(Q57780630)

6

0 references

Piotr Lewczuk

5

object named as

P. Lewczuk

0 references

author name string

M. Bibl

1

0 references

B. Mollenhauer

2

0 references

S. Wolf

3

0 references

H. Esselmann

Journal of Neural Transmission

4

0 references

publication date

25 January 2007

0 references

published in

0 references

volume

114

0 references

issue

5

0 references

page(s)

621-628

0 references

cites work

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0618-Z

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0618-Z

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0618-Z

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0618-Z

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

12 December 2020

Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy

1 reference

12 December 2020

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

1 reference

12 December 2020

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

1 reference

12 December 2020

A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques

1 reference

12 December 2020

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

12 December 2020

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

12 December 2020

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

1 reference

12 December 2020

Picking away at frontotemporal dementia

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

12 December 2020

Amyloid Abeta40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia

1 reference

12 December 2020

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

1 reference

12 December 2020

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases

1 reference

12 December 2020

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

1 reference

12 December 2020

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

12 December 2020

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

1 reference

12 December 2020

Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues

1 reference

12 December 2020

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease

1 reference

12 December 2020

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

12 December 2020

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

12 December 2020

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

1 reference

12 December 2020

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

1 reference

12 December 2020

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

1 reference

12 December 2020

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

12 December 2020

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

1 reference

12 December 2020

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies.

1 reference

12 December 2020

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

1 reference

12 December 2020